The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Biohaven Ltd (BHVN) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$0.03, or -0.10%, to $29.46. The Biohaven Ltd has recorded 15,578 volume in the after hours trading session. Most recently, Yahoo Finance reported about the stock as it publicized that Biohaven Presents Preclinical Data Demonstrating Taldefgrobep alfa Reduces Fat and Improves Lean Mass at The Obesity Society’s Annual Meeting, ObesityWeek®.
Biohaven Ltd is listed on the NYSE as a member of the Healthcare sector and is a part of the Biotechnology industry. At the end of the last regular session, the stock closed at $29.49 and fluctuated between $29.62 as its day high and $26.39 as its day low. The current market capitalization of Biohaven Ltd is $2.01B. A total of 1.2 million shares were traded on the day, compared to an average of 1.05M shares.
Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, BHVN has seen 2 BUY and 0 SELL insider trades, representing the acquisition of 150,000 and the disposition of 0 shares. Over the last 12 months, there were 2 BUYs and 0 SELLs from insiders. Insiders purchased 150,000 shares during that period but sold 0.
In the most recent transaction, CHILDS JOHN W bought 454,545 shares of BHVN for 22.00 per share on Oct 05. After the transaction, the Director now owns 3,998,952 company shares. In a previous transaction on Oct 05, Coric Vlad bought 340,908 shares at 22.00 per share. BHVN shares that Chief Executive Officer owns now total 833,120.
Among the insiders who bought shares, Coric Vlad acquired of 113,637 shares on Oct 05 at a per-share price of $22.00. This resulted in the Chief Executive Officer holding 1,657,031 shares of BHVN after the transaction. In another insider transaction, Buten Matthew bought 22,727 shares at $22.00 per share on Oct 05. Company shares held by the Chief Financial Officer now total 189,380.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for BHVN in the last 3 months, the mean price target is $27.83 with high estimates of $31.00 and low estimates of $25.00. In terms of 52-week highs and lows, BHVN has a high of $28.85 and a low of $12.35.
As of this writing, BHVN has an earnings estimate of -$1.34 per share for the current quarter. EPS was calculated based on a consensus of 7 estimates, with a high estimate of -$1.26 per share and a lower estimate of -$1.4. The company reported an EPS of -$1.03 in the last quarter, which was 27.00% higher than expectations of -$1.41.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. BHVN’s latest balance sheet shows that the firm has $76.06M in Cash & Short Term Investments as of fiscal 2021. Its Book Value Per Share was $5.67, while its Total Shareholder’s Equity was $94.69M.
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BHVN is Buy with a score of 5.00.